Jianbo Zhang

Jinan, 250117, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.

Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.

Journal: Gynecologic oncology

Published: September 12, 2025

A newly discovered Lnc-PDZD7-3 increased metastatic and proliferative potential of lung adenocarcinoma cells via modulating FN1/fibronectin signaling.

A newly discovered Lnc-PDZD7-3 increased metastatic and proliferative potential of lung adenocarcinoma cells via modulating FN1/fibronectin signaling.

Journal: Frontiers in genetics

Published: July 08, 2025

Research progress of radiation esophagitis: A narrative review.

Research progress of radiation esophagitis: A narrative review.

Journal: Medicine

Published: May 12, 2025

Sintilimab plus Anlotinib in Patients with Pretreated Locally Advanced or Metastatic Sarcoma: A Prospective, Single-Arm, Phase II Clinical Trial.

Sintilimab plus Anlotinib in Patients with Pretreated Locally Advanced or Metastatic Sarcoma: A Prospective, Single-Arm, Phase II Clinical Trial.

Journal: Cancer immunology research

Published: April 16, 2025

LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.

LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: September 23, 2022

The full management from first-line to third-line treatments in patients with Her-2-negative advanced gastric cancer.

The full management from first-line to third-line treatments in patients with Her-2-negative advanced gastric cancer.

Journal: Frontiers in oncology

Published: May 21, 2022

Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma.

Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma.

Journal: Oxidative medicine and cellular longevity

Published: March 14, 2022

A preliminary study on the association between epithelial-mesenchymal transition and circulating tumor cells in renal cell carcinoma.

A preliminary study on the association between epithelial-mesenchymal transition and circulating tumor cells in renal cell carcinoma.

Journal: Translational andrology and urology

Published: January 24, 2022

The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression.

The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression.

Journal: Frontiers in oncology

Published: July 08, 2021

Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.

Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.

Journal: Frontiers in oncology

Published: April 21, 2021

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors' Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma.

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors' Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma.

Journal: Frontiers in oncology

Published: September 08, 2020

RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells.

RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells.

Journal: Cancer cell international

Published: April 16, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026